These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16644677)

  • 1. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
    Ichinose K; Maeshima Y; Yamamoto Y; Kinomura M; Hirokoshi K; Kitayama H; Takazawa Y; Sugiyama H; Yamasaki Y; Agata N; Makino H
    Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
    Saito D; Maeshima Y; Nasu T; Yamasaki H; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F873-86. PubMed ID: 21228103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.
    Lee S; Kim W; Moon SO; Sung MJ; Kim DH; Kang KP; Jang KY; Lee SY; Park BH; Koh GY; Park SK
    Nephrol Dial Transplant; 2007 Feb; 22(2):396-408. PubMed ID: 17085463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
    Sugaru E; Nakagawa T; Ono-Kishino M; Nagamine J; Tokunaga T; Kitoh M; Hume WE; Nagata R; Taiji M
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F813-20. PubMed ID: 16278277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
    Baba M; Wada J; Eguchi J; Hashimoto I; Okada T; Yasuhara A; Shikata K; Kanwar YS; Makino H
    J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
    Cohen MP; Lautenslager GT; Hud E; Shea E; Wang A; Chen S; Shearman CW
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F789-95. PubMed ID: 17018845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
    Zhang M; Hagiwara S; Matsumoto M; Gu L; Tanimoto M; Nakamura S; Kaneko S; Gohda T; Qian J; Horikoshi S; Tomino Y
    Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.
    Chow FY; Nikolic-Paterson DJ; Ozols E; Atkins RC; Tesch GH
    J Am Soc Nephrol; 2005 Jun; 16(6):1711-22. PubMed ID: 15857924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.
    Sung SH; Ziyadeh FN; Wang A; Pyagay PE; Kanwar YS; Chen S
    J Am Soc Nephrol; 2006 Nov; 17(11):3093-104. PubMed ID: 16988063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
    Lin Y; Sun Z
    J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y
    Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
    Hagiwara S; Makita Y; Gu L; Tanimoto M; Zhang M; Nakamura S; Kaneko S; Itoh T; Gohda T; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2006 Mar; 21(3):605-15. PubMed ID: 16282336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
    Ohshiro Y; Ma RC; Yasuda Y; Hiraoka-Yamamoto J; Clermont AC; Isshiki K; Yagi K; Arikawa E; Kern TS; King GL
    Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.